Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RxSight (RXST) Depreciation & Amortization (CF) (2020 - 2025)

Historic Depreciation & Amortization (CF) for RxSight (RXST) over the last 6 years, with Q3 2025 value amounting to $854000.0.

  • RxSight's Depreciation & Amortization (CF) fell 2462.49% to $854000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.9 million, marking a year-over-year decrease of 2872.78%. This contributed to the annual value of $3.6 million for FY2024, which is 1233.45% down from last year.
  • Per RxSight's latest filing, its Depreciation & Amortization (CF) stood at $854000.0 for Q3 2025, which was down 2462.49% from $785000.0 recorded in Q2 2025.
  • In the past 5 years, RxSight's Depreciation & Amortization (CF) registered a high of $1.1 million during Q3 2024, and its lowest value of $515000.0 during Q4 2024.
  • For the 5-year period, RxSight's Depreciation & Amortization (CF) averaged around $943526.3, with its median value being $986000.0 (2021).
  • Examining YoY changes over the last 5 years, RxSight's Depreciation & Amortization (CF) showed a top increase of 1675.39% in 2024 and a maximum decrease of 5099.9% in 2024.
  • Quarter analysis of 5 years shows RxSight's Depreciation & Amortization (CF) stood at $1.0 million in 2021, then fell by 10.44% to $918000.0 in 2022, then rose by 14.49% to $1.1 million in 2023, then plummeted by 51.0% to $515000.0 in 2024, then surged by 65.83% to $854000.0 in 2025.
  • Its last three reported values are $854000.0 in Q3 2025, $785000.0 for Q2 2025, and $776000.0 during Q1 2025.